RAC - Charts & Price Action, page-4177

And it depends on -
*start points chosen ,
* time periods / larger or smaller waves . ( I don’t think waves going to be relevant anymore from here - the shares are so tightly held . Significant management and founder ownership also )

RAC is different if viewed in entirety - total increase up from lows , or starting from release of Sheba trial ( 30-40c- where RAC had pulled back to at that time .
Or after COH study release . And major new shareholders adding to position .
Board , and major re- structuring . Race oncology is like an initial explorer resources company , moved to feasibilities, and now more like a developer.
Or start point can be ~ 72c , or recent $1.60s , or time period of the last year .

And more significantly -
The IP , asset held - RAC becoming so derisked , intelligent and careful planning with best calibre of people in charge and working and advising over all , including globally .
The company is becoming so compelling for important cancer treatment areas , which we all determinedly want to see bisantrene make it to being approved for use for ( AML , Breast / ovarian / kidney , and FTO inhibition potentials in all types of cancers ) —
It is about the company seeking to prove up what it has and extend and develop on potentials - being likely taken over by a major global company , sooner in time and as a much more definite event .

This comes down to Fundamental Value , over Technical analysis. ( although TA is fun , and I appreciate and enjoy the excellent chartists in our threads . This is a price action / TA thread also )